Table 1.
Inclusion | Exclusion |
---|---|
1. Male or female aged 21–55 | 1. Lifetime history of bipolar disorder or psychosis, or first-degree relative with these conditions |
2. Physically healthy | 2. HDRS-17 > 25 or current suicidal ideation |
3. Principal DSM-5 diagnosis of OCD with illness duration ≥ 1 year and near-constant symptoms (e.g. >8 hours per day or maximum symptom-free interval <1 hour) | 3. History of significant medical condition that could increase risk of cannabis side effects |
4. YBOCS ≥ 16 | 4. Currently enrolled in or planning to begin EX/RP |
5. No psychotropic medication in last 6 weeks other than SRIs, no change to SRI dose in past 6 weeks | 5. Substance use disorder within the last year (including cannabis use disorder) or positive urine toxicology (for substances other than cannabis) at screening |
6. Prior experience using cannabis without significant adverse effects | 6. Seeking treatment for substance use |
7. Capable of providing informed consent | 7. Pregnant or nursing female |
Abbreviations: HDRS-17, Hamilton Depression Rating Scale, 17-Item; DSM-5, Diagnostic and Statistical Manual for Psychiatric Disorders, 5th Edition; OCD, Obsessive-Compulsive Disorder; YBOCS, Yale-Brown Obsessive Compulsive Scale; SRI, Serotonin Reuptake Inhibitor